Inhibikase Therapeutics, Inc. - IKT
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q2 2026
· Q1 2026
Value (USD)
Total reported value ($000)
$296.9M
QoQ value delta ($000)
+$105.5M
(+55.09%)
Implied price effect (QoQ)
+49.97%
Shares
Total shares
117,883,064
QoQ shares delta
+3,888,113
(+3.41%)
Total shares held by funds (by quarter)
Market chart (IKT)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q2 2026)
Top 25 only
Full list
Partial Q2 2026 data: 105 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.